Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 USD | +1.41% | +3.60% | +4.35% |
Mar. 18 | Sector Update: Health Care Stocks Edge Up Late Monday Afternoon | MT |
Mar. 18 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2023 * | 39.89M | Sales 2024 * | 137M | Capitalization | 278M |
---|---|---|---|---|---|
Net income 2023 * | -196M | Net income 2024 * | -236M | EV / Sales 2023 * | 1.66 x |
Net cash position 2023 * | 212M | Net cash position 2024 * | 152M | EV / Sales 2024 * | 0.92 x |
P/E ratio 2023 * |
-0.84
x | P/E ratio 2024 * |
-0.83
x | Employees | 323 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 99.63% |
Latest transcript on bluebird bio, Inc.
1 day | +1.41% | ||
1 week | +3.60% | ||
Current month | +3.60% | ||
1 month | +41.18% | ||
3 months | -52.79% | ||
6 months | -54.86% | ||
Current year | +4.35% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Obenshain
CEO | Chief Executive Officer | 51 | 15-12-31 |
Director of Finance/CFO | 51 | 22-11-06 | |
Melissa Bonner
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Vachon
CHM | Chairman | 65 | 14-07-15 |
Nick Leschly
BRD | Director/Board Member | 51 | 10-02-28 |
Richard Paulson
BRD | Director/Board Member | 56 | 23-04-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 17 M€ | -2.09% | ||
0.11% | 227 M€ | +4.29% | - | |
0.10% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 1.44 | +1.41% | 7,972,233 |
24-03-15 | 1.42 | +6.77% | 29,308,707 |
24-03-14 | 1.33 | -4.32% | 4,737,846 |
24-03-13 | 1.39 | +3.35% | 6,041,231 |
24-03-12 | 1.345 | -3.24% | 7,431,337 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.35% | 278M | |
+1.10% | 106B | |
+9.29% | 103B | |
-3.00% | 21.44B | |
-11.89% | 22.11B | |
-26.59% | 20.99B | |
-5.20% | 19.44B | |
-6.58% | 17.6B | |
+5.83% | 13.88B | |
+7.46% | 11.75B |